Advanced Therapeutics in Rheumatoid Arthritis (RA)

NCT03976245 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Etanercept
DRUG: tofacitinib

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators

[object Object]